Why the study?
Does prostaglandin E1 reduce epicardial ST segment elevation and improve regional myocardial blood flow during experimental myocardial ischemia in dogs?
Does prostaglandin E1 reduce epicardial ST segment elevation and improve regional myocardial blood flow during experimental myocardial ischemia in dogs?
Prostaglandin E1 reduces isoprenaline-stimulated myocardial ischemia in dogs via antilipolytic effects, but its primary effect without catecholamine stimulation is blood pressure reduction.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for antilipolytic protection in catecholamine-driven ischemia; leaves open translation to human acute coronary syndromes.
Riemersma et al. (1977) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: